HemaSphere
(Jun 2022)
P1224: EFFICACY OF RITUXIMAB AND BIOSIMILAR RITUXIMAB IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA, A DANISH POPULATION BASED ANALYSIS
- A. Haujir,
- M. Tøstesen,
- T. C. El-Galaly,
- T. S. Larsen,
- J. Starklint,
- C. B. Poulsen,
- P. L. Josefsson,
- E. Clasen-Linde,
- A. Dessau-Arp,
- M. R. Clausen,
- J. M. Jørgensen
Affiliations
- A. Haujir
- 1 Department of hematology, Sygehus Lillebælt, Vejle
- M. Tøstesen
- 2 Department of hematology, Aarhus University Hospital, Aarhus
- T. C. El-Galaly
- 3 Department of hematology, Aalborg Universitetshospital, Aalborg
- T. S. Larsen
- 4 Department of hematology, Odense Universitetshospital, Odense
- J. Starklint
- 5 Department of hematology, Hospitalesenheden Vest, Gødstrup
- C. B. Poulsen
- 6 Department of hematology, Sjællands Universitetshospital, Roskilde, Roskilde
- P. L. Josefsson
- 7 Department of hematology, Rigshospitalet, Copenhagen
- E. Clasen-Linde
- 7 Department of hematology, Rigshospitalet, Copenhagen
- A. Dessau-Arp
- 8 Department of hematology, Sydvestjysk Sygehus, Esbjerg, Denmark
- M. R. Clausen
- 1 Department of hematology, Sygehus Lillebælt, Vejle
- J. M. Jørgensen
- 2 Department of hematology, Aarhus University Hospital, Aarhus
- DOI
-
https://doi.org/10.1097/01.HS9.0000847760.73301.c6
- Journal volume & issue
-
Vol. 6
pp.
1110
– 1111
WeChat QR code